Published in J Bras Pneumol on March 18, 2013
Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. Am J Respir Crit Care Med (2014) 1.48
Lymphangioleiomyomatosis: differential diagnosis and optimal management. Ther Clin Risk Manag (2014) 0.93
Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations. J Bras Pneumol (2015) 0.85
Lymphangioleiomyomatosis: New Treatment Perspectives. Lung (2015) 0.78
Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM). Lung (2014) 0.77
Therapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM). Expert Opin Orphan Drugs (2014) 0.75
2016 - a second step. J Bras Pneumol (2016) 0.75
Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer. Endocrinology (2016) 0.75
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15
New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol (2007) 3.37
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86
Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med (1990) 2.76
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest (1999) 2.65
High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc (2000) 2.33
Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest (2004) 2.27
Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med (1999) 2.02
Lymphangioleiomyomatosis. Cancer Control (2006) 1.97
Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis. Hum Pathol (1990) 1.85
Clinical experience of lymphangioleiomyomatosis in the UK. Thorax (2000) 1.80
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70
Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res (2008) 1.67
Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade. J Bras Pneumol (2011) 1.55
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol (1997) 1.53
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest (2010) 1.52
Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res (1999) 1.50
Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J (2008) 1.46
Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med (2006) 1.42
Six-minute walk test: reference values for healthy adults in Brazil. J Bras Pneumol (2011) 1.39
Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke (2004) 1.33
Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med (2000) 1.32
Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest (2009) 1.28
Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol (2006) 1.26
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemother Pharmacol (1995) 1.13
Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res (1999) 1.11
Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. Chest (2007) 1.09
Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells. Am J Physiol Lung Cell Mol Physiol (2010) 1.06
Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells. Br J Pharmacol (2011) 1.04
Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol (2007) 1.01
Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration. Neurochem Int (2006) 1.01
Matrix metalloproteinases in blood from patients with LAM. Respir Med (2008) 0.97
Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. Respir Res (2012) 0.92
Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Arch Pathol Lab Med (1997) 0.92
Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res (2007) 0.83
Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis. J Bras Pneumol (2011) 0.83
Pulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis. Clinics (Sao Paulo) (2011) 0.79
Publication of the impact factor of the Brazilian Journal of Pulmonology: a milestone on a long and arduous journey. J Bras Pneumol (2012) 1.88
Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis (2007) 1.65
Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade. J Bras Pneumol (2011) 1.55
Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia. Crit Care Med (2012) 1.52
Brazilian recommendations of mechanical ventilation 2013. Part I. Rev Bras Ter Intensiva (2014) 1.35
Follow-up after acute respiratory distress syndrome caused by influenza a (H1N1) virus infection. Clinics (Sao Paulo) (2011) 1.29
First-year experience of a Brazilian tertiary medical center in supporting severely ill patients using extracorporeal membrane oxygenation. Clinics (Sao Paulo) (2012) 1.18
Highlights of the Brazilian Thoracic Association guidelines for interstitial lung diseases. J Bras Pneumol (2012) 1.11
Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration (2006) 1.08
Extracorporeal membrane oxygenation in severe hypoxemia: time for reappraisal? J Bras Pneumol (2012) 1.01
Publications in the Brazilian Journal of Pulmonology. J Bras Pneumol (2013) 0.99
Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia. Pathol Res Pract (2002) 0.93
The epidemiology of acute respiratory failure in hospitalized patients: a Brazilian prospective cohort study. J Crit Care (2010) 0.93
Evaluating humidity recovery efficiency of currently available heat and moisture exchangers: a respiratory system model study. Clinics (Sao Paulo) (2009) 0.92
Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis. Lung (2005) 0.92
Pulmonary capillary pressure in pulmonary hypertension. Crit Care (2005) 0.90
Tomographic findings of acute pulmonary toxoplasmosis in immunocompetent patients. BMC Pulm Med (2014) 0.89
Nonhomogeneous density of CD34 and VCAM-1 alveolar capillaries in major types of idiopathic interstitial pneumonia. Lung (2006) 0.89
Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias. Thorax (2007) 0.89
Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vascul Pharmacol (2005) 0.88
Pulmonary and mediastinal "sarcoidosis" following surgical resection of cancer. Pathol Res Pract (2004) 0.88
Shortening ventilatory support with a protocol based on daily extubation screening and noninvasive ventilation in selected patients. Clinics (Sao Paulo) (2011) 0.88
Prevalence rates of infection in intensive care units of a tertiary teaching hospital. Rev Hosp Clin Fac Med Sao Paulo (2003) 0.85
Brazilian recommendations of mechanical ventilation 2013. Part 2. Rev Bras Ter Intensiva (2014) 0.85
Experimental study on the efficiency and safety of the manual hyperinflation maneuver as a secretion clearance technique. J Bras Pneumol (2013) 0.85
Takotsubo cardiomyopathy triggered by β(2) adrenergic agonist. J Bras Pneumol (2011) 0.85
Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis. J Bras Pneumol (2011) 0.83
Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/idiopathic pulmonary fibrosis. Hum Pathol (2009) 0.83
Update on viral community-acquired pneumonia. Rev Assoc Med Bras (2013) 0.83
Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation in Brazil: are we ready to embark upon this new age? Clinics (Sao Paulo) (2011) 0.83
Structural features of epithelial remodeling in usual interstitial pneumonia histologic pattern. Lung (2006) 0.83
The lung in paracoccidioidomycosis: new insights into old problems. Clinics (Sao Paulo) (2013) 0.82
Ventilation strategies for acute lung injury and acute respiratory distress syndrome. JAMA (2008) 0.82
Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.82
Goal-oriented respiratory management for critically ill patients with acute respiratory distress syndrome. Crit Care Res Pract (2012) 0.82
Pneumomediastinum, subcutaneous emphysema, and pneumothorax after a pulmonary function testing in a patient with bleomycin-induced interstitial pneumonitis. J Bras Pneumol (2013) 0.81
Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases. Clinics (Sao Paulo) (2010) 0.80
Guidelines for the diagnosis of rheumatoid arthritis. Rev Bras Reumatol (2013) 0.80
Epipericardial fat necrosis: an unusual cause of chest pain. J Bras Pneumol (2013) 0.80
Pulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis. Clinics (Sao Paulo) (2011) 0.79
Age, invasive ventilatory support and outcomes in elderly patients admitted to intensive care units. Age Ageing (2009) 0.78
Infection as an independent risk factor for mortality in the surgical intensive care unit. Clinics (Sao Paulo) (2013) 0.78
Birt-Hogg-Dubé syndrome: metalloproteinase activity and response to doxycycline. Clinics (Sao Paulo) (2012) 0.78
Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM). Lung (2014) 0.77
A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM. Respir Med (2013) 0.77
Immunophenotyping and extracellular matrix remodeling in pulmonary and extrapulmonary sarcoidosis. J Bras Pneumol (2012) 0.77
Usual interstitial pneumonia: a pattern or a disease? A reflection upon the topic. J Bras Pneumol (2013) 0.77
Lung cysts in chronic paracoccidioidomycosis. J Bras Pneumol (2013) 0.77
Can patients maintain their use of everolimus until lung transplantation? Transplantation (2015) 0.77
An evaluation of respiration and swallowing interaction after orotracheal intubation. Clinics (Sao Paulo) (2010) 0.76
Recruitment maneuver and PEEP response in acute exacerbation of nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis (2004) 0.76
Comparison of two flow generators with a noninvasive ventilator to deliver continuous positive airway pressure: a test lung study. Intensive Care Med (2005) 0.76
Dynamic hyperinflation on exertion: much remains unknown. J Bras Pneumol (2012) 0.76
Evaluation of manual resuscitators used in ICUs in Brazil. J Bras Pneumol (2013) 0.75
Immunoglobulin G4-related systemic sclerosing disease in a patient with sclerosing cholangitis, inflammatory pseudotumors of the lung and multiple radiological patterns: a case report. Clinics (Sao Paulo) (2011) 0.75
The quest for the holy grail: a dead lock. Am J Respir Crit Care Med (2010) 0.75
Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil. Rev Hosp Clin Fac Med Sao Paulo (2002) 0.75
Incidence of asthma symptoms and decreased pulmonary function in young amateur swimmers. J Bras Pneumol (2009) 0.75
Effectiveness, safety and tolerability of gatifloxacin, a new 8-methoxyfluoroquinolone, in the treatment of outpatients with community-acquired pneumonia: a Brazilian study. Braz J Infect Dis (2003) 0.75
The impact factor for the Brazilian Journal of Pulmonology is arriving. J Bras Pneumol (2012) 0.75
[Pulmonary involvement in Behcet's disease: a positive single-center experience with the use of immunosuppressive therapy]. J Bras Pneumol (2008) 0.75
Evaluation of articles on pulmonology published in Brazilian journals other than the Brazilian Journal of Pulmonology. J Bras Pneumol (2012) 0.75
Transient lymphadenopathy secondary to nephrotic syndrome. Arq Bras Cardiol (2012) 0.75
Biopsy-proven pulmonary determinants of heart disease. Lung (2009) 0.75